InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Teehan Brendan, Executive. Officer active across 2 companies, notably Acadia Pharmaceuticals INC. Aggregated, 31 filings have been logged. Breakdown: 0 buy · 8 sells. Total volume traded: €494k. History available since 23 February 2022. The latest transaction was filed on 11 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Teehan Brendan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations31 total
51,714 shares0Common StockSEC:0001628280-26-008077:0
5,182 shares@ US$20.5496.0% of flowCommon StockSEC:0001628280-26-005154:0
402.268 shares@ US$10.7634.0% of flowCommon StockSEC:0001628280-26-000964:0
54,000 shares0Common StockSEC:0001396814-25-000030:0
9,913 sharesCommon StockSEC:0001415889-24-027294:0
9,913 sharesCommon StockSEC:0001415889-24-027294:1
10,329 shares@ US$16.8133.2% of flowCommon StockSEC:0001415889-24-027294:2
9,534 shares@ US$15.2826.6% of flowCommon StockSEC:0001415889-24-021726:2
5,024 shares0Common StockSEC:0001415889-24-021726:0
13,629 shares0Common StockSEC:0001415889-24-021726:1
6,814 sharesCommon StockSEC:0001415889-24-012239:0
2,568 shares@ US$17.878.6% of flowCommon StockSEC:0001415889-24-010603:1
5,024 sharesCommon StockSEC:0001415889-24-010603:0
10,048 shares0Common StockSEC:0001415889-24-009272:0
1,107 sharesCommon StockSEC:0001415889-24-005575:0
624 shares@ US$24.672.9% of flowCommon StockSEC:0001415889-24-005575:1
731 shares@ US$29.964.1% of flowCommon StockSEC:0001209191-24-001268:1
1,287 sharesCommon StockSEC:0001209191-24-001268:0
4,960 shares@ US$22.6420.8% of flowCommon StockSEC:0001209191-23-056355:2
4,956 sharesCommon StockSEC:0001209191-23-056355:0
4,956 sharesCommon StockSEC:0001209191-23-056355:1
14,869 sharesCommon StockSEC:0001209191-23-031241:0
548 shares@ US$21.182.1% of flowCommon StockSEC:0001209191-23-026744:1
1,567 shares0Common StockSEC:0001209191-23-026744:0
5,024 sharesCommon StockSEC:0001209191-23-023865:0
25 of 31 declarations
About Teehan Brendan
Teehan Brendan is an executive linked to Acadia Pharmaceuticals INC, where he is EVP, COO, HEAD OF COMMERCIAL, and to Pacira BioSciences, Inc., where he is Chief Commercial Officer. Across 31 filings, the sampled recent filings cover the period from 2022-01-10 to 2026-02-13, with 0 EUR of buys and 493857 EUR of sells, and the most common transaction nature is Levée d'options.
